Loading...
Loading...
ANIP| Name | Value |
|---|---|
| Revenues | 131.7M |
| Cost of Revenue | 68.6M |
| Gross Profit | 63.0M |
| Operating Expense | 54.3M |
| Operating I/L | 8.7M |
| Other Income/Expense | -5.8M |
| Interest Income | 0.0M |
| Pretax | 0.9M |
| Income Tax Expense | -0.2M |
| Net Income/Loss | 1.2M |
ANI Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development, manufacturing, and marketing of branded and generic prescription pharmaceuticals in the United States and Canada. The company's product portfolio includes controlled substances, oncology products, hormones and steroids, injectables, and other formulations. ANI Pharmaceuticals focuses on producing oral solid dose products, semi-solids, liquids, topicals, and potent products. Additionally, it offers contract development and manufacturing services for pharmaceutical products. The company distributes its products through retail pharmacy chains, wholesalers, distributors, mail order pharmacies, and group purchasing organizations.
